View Older Stories View More Recent Stories

May 24, 2022 06:00AM UPDATE: Cantor Fitzgerald Starts Lyra Therapeutics (LYRA) at Overweight
May 23, 2022 03:28PM Form 13F-NT/A Cantor Fitzgerald Europe For: Mar 31
May 23, 2022 03:27PM Form 13F-NT/A CANTOR FITZGERALD & CO. For: Mar 31
May 23, 2022 03:26PM Form 13F-NT/A CANTOR FITZGERALD SECURI For: Mar 31
May 23, 2022 03:24PM Form 13F-HR/A CANTOR FITZGERALD, L. For: Mar 31
May 23, 2022 03:19PM "Approval of Tyvaso DPI Marks Significant Inflection Point", Shares Present "Upside From Current Levels" - Cantor Fitzgerald Bullish on MannKind (MNKD) with $6.50 Price Target
May 20, 2022 06:04AM Sanara MedTech (SMTI) PT Lowered to $40 at Cantor Fitzgerald, Overweight Rating Maintained
May 19, 2022 07:33AM Near to go Public on Nasdaq via Merger with KludeIn I Acquisition Corp. (INKA)
May 19, 2022 07:31AM Near, a Global Leader in Privacy-Led Data Intelligence, to go Public on Nasdaq via a Merger with KludeIn I Acquisition Corp.
May 19, 2022 07:31AM /C O R R E C T I O N -- Near North America, Inc./
May 19, 2022 06:38AM Data intelligence firm Near to go public via $1 billion SPAC deal
May 19, 2022 01:04AM Investors jolted as U.S. retailers show inflation hitting consumers
May 19, 2022 01:04AM Investors jolted as U.S. retailers show inflation hitting consumers
May 19, 2022 01:04AM Investors jolted as U.S. retailers show inflation hitting consumers
May 18, 2022 09:06PM Form 4 BGC Partners, Inc. For: May 17 Filed by: CANTOR FITZGERALD, L. P.
May 18, 2022 06:10PM Cantor Fitzgerald Reiterates Overweight Rating, $53 Price Target on Insmed (INSM)
May 18, 2022 05:27PM Form 4 NEWMARK GROUP, INC. For: May 17 Filed by: CANTOR FITZGERALD, L. P.
May 18, 2022 09:37AM Allakos Inc. (ALLK) PT Lowered to $10 at Cantor Fitzgerald, But BUY Rating Maintained, "Still Believe that the Market Opportunity for lirentelimab is Underappreciated"
May 18, 2022 06:17AM Cantor Fitzgerald Reiterates Overweight Rating, $7 Price Target on VolitionRX (VNRX), Has a "More Favorable View of the Company"
May 18, 2022 06:13AM Cantor Fitzgerald Reiterates Overweight Rating, $19 Price Target on Exagen (XGN) on Alivio Health Agreement
May 18, 2022 06:02AM Form SC 13D/A Satellogic Inc. Filed by: CANTOR FITZGERALD, L. P.
May 17, 2022 05:04PM Form 424B3 Cantor Fitzgerald Income
May 17, 2022 08:43AM Enigma Securities Appoints Barry Finkelstein as Global Head of Investment Banking
May 17, 2022 07:01AM Appreciate to Go Public Via Merger with PropTech Investment Corporation II (PTICU)
May 17, 2022 07:00AM PropTech Investment Corporation II to Combine with Appreciate, Bringing Single Family Rental Marketplace & Management Platform, Renters Warehouse, to the Public Markets
May 17, 2022 07:00AM PropTech Investment Corporation II to Combine with Appreciate, Bringing Single Family Rental Marketplace & Management Platform, Renters Warehouse, to the Public Markets
May 17, 2022 06:48AM Cantor Fitzgerald Reiterates Neutral Rating on TherapeuticsMD (TXMD)
May 17, 2022 06:13AM UPDATE: Aytu Biosciences (AYTU) PT Lowered to $5 at Cantor Fitzgerald, "Overweight" Rating Reiterated, Analyst Expects "Upwards Earnings Revisions Should Drive Shares Higher"
May 17, 2022 06:13AM Spero Therapeutics (SPRO) PT Slashed to $5 at Cantor Fitzgerald, Analyst Maintains "Overweight" Rating
May 16, 2022 05:52PM Form 13F-NT CANTOR FITZGERALD & CO. For: Mar 31
May 16, 2022 05:33PM Form 13F-HR CANTOR FITZGERALD, L. For: Mar 31
May 16, 2022 05:18PM Form 13F-NT CANTOR FITZGERALD SECURI For: Mar 31
May 16, 2022 05:02PM Form 13F-NT Cantor Fitzgerald Europe For: Mar 31
May 16, 2022 04:42PM Form 10-Q Cantor Fitzgerald Income For: Mar 31
May 16, 2022 03:43PM Form SC 13G Cartesian Growth Corp Filed by: CANTOR FITZGERALD SECURITIES
May 16, 2022 09:49AM Cantor Fitzgerald Reiterates Overweight Rating. $15 Price Target on ContraFect (CFRX), "Expect Upwards Earnings Revision to Move Share Higher"
May 16, 2022 07:00AM Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights
May 16, 2022 07:00AM Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights
May 16, 2022 06:49AM UPDATE: Benchmark Downgrades Shift Technologies Inc. (SFT) to Hold
May 16, 2022 05:27AM Lionheart Acquisition Corporation II (LCAPU) Enters Non-Binding Term Sheets for Forward Purchase Agreement and Committed Equity Facility with Cantor Fitzgerald
May 13, 2022 06:23PM Lionheart Acquisition Corporation II Enters into Non-Binding Term Sheets for Forward Purchase Agreement and Committed Equity Facility with Cantor Fitzgerald L.P.
May 13, 2022 04:18PM Cantor Fitzgerald Assumes Poseida Therapeutics, Inc (PSTX) at Overweight
May 13, 2022 02:43PM Cantor Fitzgerald Assumes Harpoon Therapeutics (HARP) at Overweight
May 13, 2022 07:01AM CF Acquisition Corp. VI (CFVI) and Rumble File Amended Registration Statement for Proposed Merger
May 13, 2022 07:00AM CF Acquisition Corp. VI and Rumble Announce Filing of Amended Registration Statement in Connection with their Proposed Business Combination
May 13, 2022 06:27AM Cantor Fitzgerald Reiterates VYNE Therapeutics (VYNE) at Overweight with $10 Price Target, Expects "Upwards Earnings Estimate Revisions and Multiple Expansion"
May 13, 2022 06:25AM Cantor Fitzgerald Reiterates Overweight Rating on Fortress Biotech (FBIO) on Q1 Report, "Risk-Diversification Remains Attractive "
May 13, 2022 06:19AM Cantor Fitzgerald Reiterates Overweight Rating on Checkpoint Therapeutics (CKPT) on Q1 Report
May 13, 2022 06:10AM Cantor Fitzgerald Reiterates Overweight Rating, $5 on PAVmed (PAVM), "Encourage Investors to Acquire PAVM Shares at Attractive Valuation"
May 12, 2022 10:12PM BancTrust & Co. Investment Bank Announces Launch of U.S. Broker-Dealer Affiliate
View More Recent Stories View Older Stories